Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06493032 · ClinicalTrials.gov registry record · NA

The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM

A NA study of Gastroparesis, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06493032 is a NA study of Gastroparesis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 20 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06493032, a NA study of Gastroparesis, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate whether or not the investigators can utilize Body Surface Gastric Mapping to determine who would best benefit to receive G-POEM procedure and how Body Surface Gastric Mapping can be utilized with patients who have gastroparesis symptoms. the investigators may also be able to find more ways how Body Surface Gastric Mapping testing can benefit patients with gastroparesis and/or G-POEM procedure.

Conditions Studied

Interventions

  • DEVICE Gastric Alimetry System

Study Locations (1)

Indiana

  • Indiana University Health University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-11-07
Est. Completion 2026-06-01
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT06493032

The ClinicalTrials.gov registry entry for NCT06493032 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (93% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Gastric Alimetry System is the first listed.

NCT06493032 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06493032 about?

NCT06493032 is a clinical study titled "The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM". The purpose of this study is to investigate whether or not the investigators can utilize Body Surface Gastric Mapping to determine who would best benefit to receive G-POEM procedure and how Body Surface Gastric Mapping can be utilized with patients who have gastroparesis symptoms. the investigators ...

What is the current status of trial NCT06493032?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-11-07. Estimated completion is 2026-06-01.

What conditions does trial NCT06493032 study?

This clinical trial studies the following conditions: Gastroparesis.

What interventions are being tested in trial NCT06493032?

The interventions under investigation include: Gastric Alimetry System (DEVICE).

Who is sponsoring clinical trial NCT06493032?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06493032 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.